Comparison between Ekennis Software IPO and Vaidya Sane Ayurved Laboratories IPO.
Ekennis Software IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vaidya Sane Ayurved Laboratories IPO is a SME Fixed Price proposed to list at NSE SME.
| Ekennis Software IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Shreni Shares Ltd. | First Overseas Capital Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | Bhh Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ekennis Software IPO is up to ₹2.72 Cr whereas the issue size of the Vaidya Sane Ayurved Laboratories IPO is up to ₹19.20 Cr. The final issue price of Ekennis Software IPO is ₹72.00 per share and of Vaidya Sane Ayurved Laboratories IPO is ₹73.00 per share.
| Ekennis Software IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹72.00 per share | ₹73.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 3,77,600 shares | 26,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹2.72 Cr | up to ₹19.20 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 3,77,600 shares | 26,30,400 shares |
| Issue Size Total (Amount) | up to ₹2.72 Cr | up to ₹19.20 Cr |
Ekennis Software IPO opens on Feb 21, 2022, while Vaidya Sane Ayurved Laboratories IPO opens on Feb 10, 2022. The closing date of Ekennis Software IPO and Vaidya Sane Ayurved Laboratories IPO is Feb 24, 2022, and Feb 15, 2022, respectively.
| Ekennis Software IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Issue Open | Feb 21, 2022 | Feb 10, 2022 |
| Issue Close | Feb 24, 2022 | Feb 15, 2022 |
| Basis Of Allotment (Tentative) | Mar 02, 2022 | Feb 18, 2022 |
| Initiation of Refunds (Tentative) | Mar 03, 2022 | Feb 21, 2022 |
| Credit of Share (Tentative) | Mar 04, 2022 | Feb 22, 2022 |
| Listing date (Tentative) | Mar 07, 2022 | Feb 23, 2022 |
Ekennis Software IPO P/E ratio is 11.4, as compared to Vaidya Sane Ayurved Laboratories IPO P/E ratio of 28.29.
| Ekennis Software IPO | Vaidya Sane Ayurved Laboratories IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100% | 90.08% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.42% | 66.34% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.4 | 28.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹10.08 Cr. | ₹76.75 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 126.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 173.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹189.83 | ₹2.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 77.48 | 15.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Ekennis Software IPO Retail Individual Investors (RII) are offered 1,88,800 shares while in Vaidya Sane Ayurved Laboratories IPO retail investors are offered 1,88,800 shares. Qualified Institutional Buyers (QIB) are offered in Ekennis Software IPO and in Vaidya Sane Ayurved Laboratories IPO.
| Ekennis Software IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Market Maker Reservation | 22,400 shares | 1,40,800 shares |
| NII | 1,88,800 shares | 13,15,200 shares |
| RII | 1,88,800 shares | 13,15,200 shares |
| Total | 3,77,600 shares | 26,30,400 shares |
Ekennis Software IPO subscribed 28.00x in total, whereas Vaidya Sane Ayurved Laboratories IPO subscribed 2.82x.
| Ekennis Software IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| NII (times) | 36.99x | 2.66x |
| RII (times) | 19.00x | 2.98x |
| Total (times) | 28.00x | 2.82x |
